Table 2 Descriptions of complications in the included studies
Author | study design | G1(CPSNB) / G2(SPSNB) | Complications |
|---|---|---|---|
Ding 2015 | RCT | 23/21 | G1: 5/23 catheter dislodge; 2/23 pump malfunction |
Elliot 2010 | RCT | 27/27 | All: 6/54 drug leakage, 2/54 catheter blockade, 1/54 catheter dislodge, 1/54 pump malfunction G1:0/27 adverse drug reaction G2:1/27 numbness on foot dorsum for 5 days, recovered |
Zaric 2004 | RCT | 30/30 | All: 5/60 drug leakage,5/60 difficult adaptation to the device, 1/60 catheter dislodge, G1: 0/30 adverse drug reaction |
White 2003 | RCT | 10/10 | G1:8/10 “tingling sensation” in the foot G2:1/10 “tingling sensation” in the foot |
Ilfeld 2002 | RCT | 15/15 | All: 15/30 drug leakage, 9/30 nonscheduled contact with the physician, 2/30 catheter dislodge, 1/30 pump malfunction |